Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Affinivax Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 31 May 2022 | GlaxoSmithKline (GSK) Acquires Affinivax | Acquisition |
GSK plc
|
Affinivax Inc |
| 28 Feb 2022 | Affinivax to Reacquire Rights to Streptococcus pneumoniae Vaccine Candidate from Astellas Pharma | Licensing Agreement |
Affinivax Inc
|
Astellas Pharma Inc |
| 13 Dec 2021 | Coalition for Epidemic Preparedness Innovations (CEPI) and Affinivax Enter into Partnership to Develop COVID-19 Vaccine to Target Variants | Partnership | - |
Coalition for Epidemic Preparedness Innovations
Affinivax Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer